Project Grant R01HL174685
Award Date
9/15/24
Completion Date
8/31/29
Dollars Obligated
$689K
Funding Federal Agency
National Institute of Diabetes and Digestive and Kidney Diseases
Awarding Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60637, USA
Similar Awards
This $684,116 Project Grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) aims to examine the mechanisms by which improving sleep regularity affects glycemic control and cardiovascular disease (CVD) risk in adults with type 1 diabetes. The grant will fund a 4-week behavioral sleep stability intervention in 80 adults with type 1 diabetes and irregular sleep...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) provides $524,390 to the University of Colorado-Denver to study the relationship between sleep health, circadian timing, and cardiometabolic risk in adolescents with type 1 diabetes. The research aims to utilize a combined sleep health and circadian timing intervention as a mechanistic probe to...
This Project Grant award of $190,686 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will fund a longitudinal study to investigate the relationship between sleep characteristics, hypothalamic signaling, and metabolic risk in children. The study aims to translate important findings from animal models to human research by leveraging an established cohort of 200 children...
The federal Project Grant award for "MICROMANAGING HUMAN SLEEP PHYSIOLOGY TO TREAT SLEEP APNEA AND OTHER DISORDERS" was provided by the National Institutes of Health (NIH) through the Trans-NIH Research Support program (CFDA 93.310). The $1,120,000.00 award to Northwestern University, a private research institution, will fund a 5-year research project focused on advancing scientific understanding of human sleep physiology and developing new approaches to treat sleep apnea and related...
This federal Project Grant award, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), aims to evaluate a telehealth-delivered adaptive intervention that promotes continuous positive airway pressure (CPAP) adherence and improves health outcomes for adults newly diagnosed with obstructive sleep apnea (OSA). The $1,415,112 award will fund a research study to compare the effects of motivational enhancement, device...
This Project Grant award of $449,861 from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will fund a 24-month clinical observational feasibility study to examine dental practitioners' oral appliance therapy (OAT) titration methods and outcomes for patients with obstructive sleep apnea (OSA). The study will recruit 10 dental practitioners and 60 OSA patients over 12 months. Practitioners will provide...
This $740,271 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research to assess the prevalence of undiagnosed obstructive sleep apnea (OSA) in primary care clinics, identify barriers to OSA diagnosis, and develop predictive tools for OSA risk and subtypes. The principal investigators are from The Ohio State University and the University of Pennsylvania. The sub-award to the University of...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Johns Hopkins University a $599,160 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant will fund a 5-year research study titled "NIGHT OWL METABOLISM: INVESTIGATING THE IMPACT OF CHRONOTYPE ON GLUCOSE METABOLISM IN YOUTH" led by Dr. Talia Hitt. The study aims to investigate whether aligning glucose metabolic testing and first...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), part of the Cardiovascular Diseases Research program (CFDA 93.837), provides $711,226 to the University of California, Los Angeles (UCLA) to conduct research on the impacts of obstructive sleep apnea (OSA) on the brain. The objectives are to: 1) examine regional brain temperatures in OSA patients compared to controls; 2) assess whole-brain metabolite and antioxidant levels in OSA and controls; 3)...
This federal Project Grant award of $332,862.00 from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research (CFDA 93.837) program, will support research to assess night-to-night variability in novel sleep disordered breathing severity metrics and their impact on daytime functioning. The study aims to characterize reliable biomarkers of obstructive sleep apnea (OSA) severity, as the current standard measure (Apnea-Hypopnea Index) underestimates...